Image Source: Fox Business
Inventia Healthcare chlorthalidone tablet recall news is drawing attention nationwide after thousands of bottles of a widely used blood pressure medication failed quality testing, according to the Food and Drug Administration.
India-based Inventia Healthcare Ltd. initiated a voluntary recall in September for 13,567 bottles of chlorthalidone tablets in the 25-milligram dosage. The FDA enforcement report said the tablets did not dissolve properly, raising concerns that the medication may not release as intended in the body.
Urgent Inventia Healthcare Chlorthalidone Tablet Recall Details
Chlorthalidone is a prescription diuretic commonly used to help manage high blood pressure and fluid retention. It works by helping the body remove excess salt and water, which can reduce the amount of fluid moving through the blood vessels.
The affected medication was distributed in bottles containing 100 tablets. Consumers and healthcare professionals can identify the recalled product using the following information:
- Medication: Chlorthalidone tablets
- Strength: 25 milligrams
- Quantity: 13,567 bottles
- National Drug Code: 64980-599-01
- Expiration date: April 2027
- Manufacturer: Inventia Healthcare Ltd.
The FDA classified the action as a Class II recall. The agency defines a Class II recall as a situation in which exposure to a violative product may cause temporary or medically reversible adverse health consequences, or when the likelihood of serious harm is considered remote.
Why the Blood Pressure Medication Was Recalled
The central issue involves dissolution, a quality characteristic that determines how a tablet breaks down after it is taken. If a tablet does not dissolve correctly, the active ingredient may not become available in the expected way. That could potentially affect how consistently the medication works.
According to the FDA information cited by Fox Business, Inventia Healthcare had previously recalled the same product in June for identical dissolution issues. The latest action affects more than 13,000 bottles and underscores the importance of quality-control testing for prescription medicines.
The recall does not mean every chlorthalidone tablet is defective. It applies to the product identified by the listed dosage, National Drug Code and expiration information. Patients should compare those details with the label on their own prescription bottle.
What Patients Should Do Now
People who take chlorthalidone should not stop taking the medication abruptly without speaking with a doctor or pharmacist. Blood pressure treatment plans are individualized, and suddenly missing doses could create health risks for some patients.
Instead, consumers should carefully check their bottle and contact the dispensing pharmacy or prescribing healthcare professional if they believe they have an affected product. A pharmacist can help determine whether the medication is included in the recall and explain whether a replacement or alternative prescription is appropriate.
Patients should also avoid throwing away prescription medication before receiving professional guidance. Pharmacies may have specific procedures for returns, replacements or disposal. Anyone who experiences unusual symptoms or has concerns about blood pressure control should contact a healthcare provider promptly.
Potential Impact on Consumers
Chlorthalidone is used by patients managing hypertension, a condition that often requires consistent daily treatment. It may also be prescribed for fluid retention associated with certain medical conditions. Because the recalled tablets may have dissolution problems, the main concern is whether patients receive the intended effect from the medication.
The FDA’s Class II classification indicates that serious consequences are considered unlikely, but it does not eliminate the need for caution. Medication recalls are issued so consumers and healthcare professionals can identify potentially affected products before additional problems occur.
Inventia Healthcare was contacted for comment regarding the recall. Consumers should rely on their healthcare providers and official FDA recall information for the latest guidance, rather than changing their treatment based on social media posts or unverified reports.
Frequently Asked Questions
What medication is included in the recall?
The recall involves 25-milligram chlorthalidone tablets manufactured by Inventia Healthcare Ltd. The affected bottles contain 100 tablets and have National Drug Code 64980-599-01.
Why was chlorthalidone recalled?
The tablets failed dissolution testing, meaning they did not dissolve properly during quality checks. The same product was also recalled in June for identical dissolution concerns.
What does a Class II recall mean?
A Class II recall means the product could cause temporary or medically reversible health effects, while the likelihood of serious harm is considered remote.
Should patients stop taking chlorthalidone?
Patients should not stop or change prescription treatment without first consulting a doctor or pharmacist. A healthcare professional can confirm whether the bottle is affected and recommend the safest next step.
How can consumers check whether their bottle is affected?
Consumers should compare the medication name, 25-milligram strength, National Drug Code, bottle quantity and expiration date with the recall information, then contact their pharmacy for confirmation.
